Sponsor:
Jazz Pharmaceuticals
Code:
NCT07723976
Conditions
Developmental and Epileptic Encephalopathy (DEE)
Eligibility Criteria
Sex: All
Age: 1+
Healthy Volunteers: Not accepted
Interventions
CBD-OS
Placebo
Brief summary:
Conditions
Developmental and Epileptic Encephalopathy (DEE)
Study ID
NCT07723976
Start date
Oct 30, 2026
Status verified date
Nov, 2026
Completion date
Sep 4, 2029
Anticipated
Primary completion date
Sep 4, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 1+
Healthy Volunteers: Not accepted
Enrollment
120 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: CBD-OS
placebo comparator: Placebo
experimental: Open-Label Extension: CBD-OS
Interventions
CBD-OS
Placebo
Primary outcome measure
Central contacts
Locations
Hawaii Pacific Neuroscience (HPN) Comprehensive Epilepsy Center
Recruiting
Honolulu, Hawaii, United States, 96817
Mid Atlantic Epilepsy And Sleep Center (ESC)
Recruiting
Bethesda, Maryland, United States, 20817
Sponsor
Jazz Pharmaceuticals
Last update posted
Nov 17, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-18. This information was provided to ClinicalTrials.gov by Jazz Pharmaceuticals on 2026-11-17. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.